MSD has acquired Yale University spinout Modifi Biosciences, claiming ownership of a potential new class of therapeutics for difficult-to-treat brain tumours, including glioblastomas. Under the terms ...

MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on finding new therapeutic targets in inflammatory bowel disease (IBD). The ...

Here’s our Helldivers 2 ship modules tier list based on the time we’ve spent in-game. Since they’re all passive buffs, you don’t have to pick between them. Instead, pick what to upgrade first and get ...